Skip to main content

Advertisement

SpringerLink
Log in

One-step fabrication of bicompartmental microparticles as a dual drug delivery system for Parkinson’s disease management

  • Materials for life sciences
  • Published:
Journal of Materials Science Aims and scope Submit manuscript

Abstract

Parkinson’s disease (PD) is a progressive neurodegenerative disorder primarily affecting elderly patients. In order to efficiently manage the symptoms of the disease, controlled and continuous supply of PD drugs [levodopa (LD) and carbidopa (CD)] would be highly beneficial. Currently available commercial tablets are not sufficiently capable of releasing PD drugs in a sustainable fashion. Hence, the purpose of this study was to engineer a carrier system to deliver more than one therapeutic to the target site with independent, sustainable release kinetics. To achieve that, we have designed and developed a set of disk-shaped microparticles composed of two distinct compartments, the first containing a relatively hydrophilic amorphous polymer, poly(lactide-co-glycolide) and the second composed entirely of hydrophobic semicrystalline polylactide. These bicompartmental microparticles with narrow particle size distribution (coefficient of variance ~ 6%) were fabricated by electrohydrodynamic co-jetting technique and characterized by optical microscopy, confocal laser scanning microscopy, SEM, DSC and Raman microscopy. The feasibility of the bicompartmentalized microparticles was confirmed by localizing two different hydrophilic PD drugs (LD and CD) in two different compartments with 4:1 ratio similar to commercially available tablets. This one-step particle fabrication method generated bicompartmental particles with high drug encapsulation efficiency (LD: > 97% and CD: > 68%). The resulting dual drug-loaded disk-shaped microparticles demonstrated simultaneous release of two independent PD drugs with similar release pattern (> 80% release of both drugs within 5 h). These compartmentalized microparticles can potentially act as dual drug delivery system to enable controlled, sustained release of a wide range of water soluble drugs including PD drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Garbayo E, Ansorena E, Blanco-Prieto MJ (2013) Drug development in Parkinson’s disease: from emerging molecules to innovative drug delivery systems. Maturitas 76(3):272–278

    Article  CAS  Google Scholar 

  2. Maysinger D, Jalsenjak V, Stolnik S, Jalsenjak I (1992) Release of l-Dopa from HSA microspheres into the rat brain: in vitro and in vivo characterization by microdialysis. In: Whateley TL (ed) Microencapsulation of drugs. Harwood Academic Publication, Chur, pp 269–275

    Google Scholar 

  3. During MJ, Freese A, Sabel BA, Saltzman WM, Deutch A, Roth RH, Langer R (1989) Controlled release of dopamine from a polymeric brain implant: in vivo characterization. Ann Neurol 25(4):351–356

    Article  CAS  Google Scholar 

  4. Vallbacka JJ, Nobrega JN, Sefton MV (2001) Tissue engineering as a platform for controlled release of therapeutic agents: implantation of microencapsulated dopamine producing cells in the brains of rats. J Control Release 72(1):93–100

    Article  CAS  Google Scholar 

  5. Bianchine JR, McGhee B (1985) MPTP and parkinsonism. Ration Drug Ther 19(2):5–7

    CAS  Google Scholar 

  6. Hr A, Michel P, Giovanni A, Linda M, Nalina D, Algirdas K (2009) Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson’s disease. Mov Disord 24(4):541–550

    Article  Google Scholar 

  7. Mathers SE, Kempster PA, Swash M, Lees AJ (1988) Constipation and paradoxical puborectalis contraction in anismus and Parkinson’s disease: a dystonic phenomenon? J Neurol Neurosurg Psychiatry 51(12):1503–1507

    Article  CAS  Google Scholar 

  8. Buckley G (1989) Martindale: the extra pharmacopoeia (29th edition). J R Coll Gen Pract 39(327):440

    Google Scholar 

  9. Seeberger LC, Hauser RA (2009) Levodopa/carbidopa/entacapone in Parkinson’s disease. Expert Rev Neurother 9(7):929–940

    Article  CAS  Google Scholar 

  10. Sharma S, Lohan S, Murthy RSR (2014) Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery. Drug Dev Ind Pharm 40(7):869–878

    Article  CAS  Google Scholar 

  11. Arıca B, Kaş HS, Moghdam A, Akalan N, Hıncal AA (2005) Carbidopa/levodopa-loaded biodegradable microspheres: in vivo evaluation on experimental Parkinsonism in rats. J Control Release 102(3):689–697

    Article  Google Scholar 

  12. Baek J-S, Choo CC, Qian C, Tan NS, Shen Z, Loo SCJ (2016) Multi-drug-loaded microcapsules with controlled release for management of Parkinson’s disease. Small 12(27):3712–3722

    Article  CAS  Google Scholar 

  13. Parhizkar M, Reardon PJT, Knowles JC, Browning RJ, Stride E, Barbara PR, Harker AH, Edirisinghe M (2016) Electrohydrodynamic encapsulation of cisplatin in poly (lactic-co-glycolic acid) nanoparticles for controlled drug delivery. Nanomed Nanotechnol Biol Med 12(7):1919–1929

    Article  CAS  Google Scholar 

  14. Taylor G (1964) Disintegration of water drops in an electric field. Proc R Soc A Math Phys Eng Sci 280(1382):383–397

    Article  Google Scholar 

  15. Bhaskar S, Lahann J (2009) Microstructured materials based on multicompartmental fibers. J Am Chem Soc 131(19):6650–6651

    Article  CAS  Google Scholar 

  16. Roh K-H, Martin DC, Lahann J (2006) Triphasic nanocolloids. J Am Chem Soc 128(21):6796–6797

    Article  CAS  Google Scholar 

  17. Bhaskar S, Hitt J, Chang SW, Lahann J (2009) Multicompartmental microcylinders. Angew Chem 48(25):4589–4593 (international ed in English)

    Article  CAS  Google Scholar 

  18. Roh KH, Martin DC, Lahann J (2005) Biphasic Janus particles with nanoscale anisotropy. Nat Mater 4(10):759–763

    Article  CAS  Google Scholar 

  19. Bhaskar S, Pollock KM, Yoshida M, Lahann J (2010) Towards designer microparticles: simultaneous control of anisotropy, shape, and size. Small 6(3):404–411

    Article  CAS  Google Scholar 

  20. Lee KJ, Yoon J, Rahmani S, Hwang S, Bhaskar S, Mitragotri S, Lahann J (2012) Spontaneous shape reconfigurations in multicompartmental microcylinders. Proc Natl Acad Sci 109(40):16057–16062. https://doi.org/10.1073/pnas.1213669109

    Article  Google Scholar 

  21. Naraharisetti PK, Ning Lew MD, Fu Y-C, Lee D-J, Wang C-H (2005) Gentamicin-loaded discs and microspheres and their modifications: characterization and in vitro release. J Control Release 102(2):345–359

    Article  CAS  Google Scholar 

  22. Ahmed A, Bonner C, Desai TA (2002) Bioadhesive microdevices with multiple reservoirs: a new platform for oral drug delivery. J Control Release 81(3):291–306

    Article  CAS  Google Scholar 

  23. Banerjee A, Qi J, Gogoi R, Wong J, Mitragotri S (2016) Role of nanoparticle size, shape and surface chemistry in oral drug delivery. J Control Release 238:176–185. https://doi.org/10.1016/j.jconrel.2016.07.051

    Article  CAS  Google Scholar 

  24. Liu Y, Tan J, Thomas A, Ou-Yang D, Muzykantov VR (2012) The shape of things to come: importance of design in nanotechnology for drug delivery. Ther Deliv 3(2):181–194. https://doi.org/10.4155/tde.11.156

    Article  CAS  Google Scholar 

  25. Fan J, Guo Y, Wang J, Fan M (2009) Rapid decolorization of azo dye methyl orange in aqueous solution by nanoscale zerovalent iron particles. J Hazard Mater 166(2):904–910

    Article  CAS  Google Scholar 

  26. Rao AV, Shiwnarain N, Maharaj I (1989) Survival of microencapsulated Bifidobacterium pseudolongum in simulated gastric and intestinal juices. Can Inst Food Sci Technol J 22(4):345–349

    Article  Google Scholar 

  27. Marques M (2004) Dissolution media simulating fasted and fed states. Dissolut Technol 11:16–19

    Article  Google Scholar 

  28. Sharma B (2017) Synthesis of fluorene and cyclopentadithiophene based donor-acceptor type low band-gap cross-conjugated polymers for solar cell applications. IIT, Delhi

    Google Scholar 

  29. Lee WL, Loei C, Widjaja E, Loo SCJ (2011) Altering the drug release profiles of double-layered ternary-phase microparticles. J Control Release 151(3):229–238

    Article  CAS  Google Scholar 

  30. Kim K, Yu M, Zong X, Chiu J, Fang D, Seo Y-S, Hsiao BS, Chu B, Hadjiargyrou M (2003) Control of degradation rate and hydrophilicity in electrospun non-woven poly(d, l-lactide) nanofiber scaffolds for biomedical applications. Biomaterials 24(27):4977–4985

    Article  CAS  Google Scholar 

  31. Park TG (1995) Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition. Biomaterials 16(15):1123–1130

    Article  CAS  Google Scholar 

  32. Bhaskar S, Roh K-H, Jiang X, Baker GL, Lahann J (2008) Spatioselective modification of bicompartmental polymer particles and fibers via huisgen 1,3-dipolar cycloaddition. Macromol Rapid Commun 29(20):1655–1660

    Article  CAS  Google Scholar 

  33. Müller T, Erdmann C, Bremen D, Schmidt WE, Muhlack S, Woitalla D, Goetze O (2006) Impact of gastric emptying on levodopa pharmacokinetics in Parkinson disease patients. Clin Neuropharmacol 29(2):61–67

    Article  Google Scholar 

  34. Koombhongse S, Liu W, Reneker DH (2001) Flat polymer ribbons and other shapes by electrospinning. J Polym Sci, Part B: Polym Phys 39(21):2598–2606

    Article  CAS  Google Scholar 

  35. Xie J, Lim LK, Phua Y, Hua J, Wang C-H (2006) Electrohydrodynamic atomization for biodegradable polymeric particle production. J Colloid Interface Sci 302(1):103–112

    Article  CAS  Google Scholar 

  36. Doshi N, Zahr AS, Bhaskar S, Lahann J, Mitragotri S (2009) Red blood cell-mimicking synthetic biomaterial particles. Proc Natl Acad Sci 106(51):21495–21499

    Article  CAS  Google Scholar 

  37. Arias V, Odelius K, Albertsson A-C (2014) Nano-stereocomplexation of polylactide (PLA) spheres by spray droplet atomization. Macromol Rapid Commun 35(22):1949–1953

    Article  CAS  Google Scholar 

  38. Lahann J, Hwang SY, Yoon J, Bhaskar S, Lee K, Park TH (2016) Optical devices with switchable particles. Google Patents

  39. Bhaskar S, Gibson CT, Yoshida M, Nandivada H, Deng X, Voelcker NH, Lahann J (2011) Engineering, characterization and directional self-assembly of anisotropically modified nanocolloids. Small 7(6):812–819

    Article  CAS  Google Scholar 

  40. Rahmani S, Saha S, Durmaz H, Donini A, Misra AC, Yoon J, Lahann J (2014) Chemically orthogonal three-patch microparticles. Angew Chem Int Ed Engl 53(9):2332–2338

    Article  CAS  Google Scholar 

  41. Lee WL, Widjaja E, Loo SCJ (2010) One-step fabrication of triple-layered polymeric microparticles with layer localization of drugs as a novel drug-delivery system. Small 6(9):1003–1011. https://doi.org/10.1002/smll.200901985

    Article  CAS  Google Scholar 

  42. Bhaskar S (2011) Multicompartmental biomaterials via electrohydrodynamic co-jetting, chapter-9. PhD thesis, University of Michigan, Ann Arbor

  43. Sungkapreecha C, Iqbal N, Gohn AM, Focke WW, Androsch R (2017) Phase behavior of the polymer/drug system PLA/DEET. Polymer 126(Supplement C):116–125

    Article  CAS  Google Scholar 

  44. Edwin B, Hubert Joe I (2013) Vibrational spectral analysis of anti-neurodegenerative drug Levodopa: a DFT study. J Mol Struct 1034:119–127

    Article  CAS  Google Scholar 

  45. Frazao NF, Albuquerque EL, Fulco UL, Mauriz PW, Azevedo DL (2013) Optoelectronics and vibrational properties of carbidopa from quantum chemistry computations. Indian Ocean Rev Sci Technol 1:1–12

    Google Scholar 

  46. Sukker GM, Wazzan N, Hilaal R (2015) Towards understanding mode of action of L-Dopa and carbidopa: DFT/TD-DFT analyse of their electronic and vibrational spectra. Indian J Chem 54A:1378–1386

    CAS  Google Scholar 

  47. Mittur A, Gupta S, Modi NB (2017) Pharmacokinetics of Rytary®, an extended-release capsule formulation of carbidopa–levodopa. Clin Pharmacokinet 56(9):999–1014

    Article  CAS  Google Scholar 

  48. F-d Cui, A-j Tao, D-m Cun, L-q Zhang, Shi K (2007) Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery. J Pharm Sci 96(2):421–427

    Article  Google Scholar 

  49. Feng S-S, Mei L, Anitha P, Gan CW, Zhou W (2009) Poly(lactide)–vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of docetaxel. Biomaterials 30(19):3297–3306

    Article  CAS  Google Scholar 

  50. Italia JL, Bhatt DK, Bhardwaj V, Tikoo K, Kumar MNVR (2007) PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral®. J Control Release 119(2):197–206

    Article  CAS  Google Scholar 

  51. Tobío M, Sánchez A, Vila A, Soriano I, Evora C, Vila-Jato JL, Alonso MJ (2000) The role of PEG on the stability in digestive fluids and in vivo fate of PEG–PLA nanoparticles following oral administration. Colloids Surf B 18(3):315–323

    Article  Google Scholar 

  52. Foss AC, Goto T, Morishita M, Peppas NA (2004) Development of acrylic-based copolymers for oral insulin delivery. Eur J Pharm Biopharm 57(2):163–169

    Article  CAS  Google Scholar 

  53. Hu Y, Jiang X, Ding Y, Ge H, Yuan Y, Yang C (2002) Synthesis and characterization of chitosan–poly(acrylic acid) nanoparticles. Biomaterials 23(15):3193–3201

    Article  CAS  Google Scholar 

  54. Ensign LM, Cone R, Hanes J (2012) Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev 64(6):557–570

    Article  CAS  Google Scholar 

  55. Khonsari F, Zakeri-Milani P, Jelvehgari M (2014) Formulation and Evaluation of In-vitro Characterization of Gastic-Mucoadhesive Microparticles/Discs Containing Metformin Hydrochloride. Iran J Pharm Res IJPR 13(1):67–80

    CAS  Google Scholar 

  56. Lennernas H (2007) Modeling gastrointestinal drug absorption requires more in vivo biopharmaceutical data: experience from in vivo dissolution and permeability studies in humans. Curr Drug Metab 8(7):645–657

    Article  Google Scholar 

  57. Thwaites DT, Anderson CMH (2007) H + -coupled nutrient, micronutrient and drug transporters in the mammalian small intestine. Exp Physiol 92(4):603–619

    Article  CAS  Google Scholar 

  58. Tang Y-D, Venkatraman SS, Boey FYC, Wang L-W (2007) Sustained release of hydrophobic and hydrophilic drugs from a floating dosage form. Int J Pharm 336(1):159–165

    Article  CAS  Google Scholar 

  59. Liu Y, Zhang J, Gao Y, Zhu J (2011) Preparation and evaluation of glyceryl monooleate-coated hollow-bioadhesive microspheres for gastroretentive drug delivery. Int J Pharm 413(1):103–109

    Article  CAS  Google Scholar 

  60. Drugbank Levodopa and Carbidopa. https://www.drugbank.ca/drugs/DB01235, https://www.drugbank.ca/drugs/DB00190

  61. Martini LG, Avontuur P, George A, Willson RJ, Crowley PJ (1999) Solubility parameter and oral absorption. Eur J Pharm Biopharm 48(3):259–263

    Article  CAS  Google Scholar 

  62. Liu H, Finn N, Yates MZ (2005) Encapsulation and sustained release of a model drug, indomethacin, using CO2-based microencapsulation. Langmuir 21(1):379–385

    Article  CAS  Google Scholar 

  63. Siepmann J, Peppas NA (2001) Mathematical modeling of controlled drug delivery. Adv Drug Deliv Rev 48(2–3):137–138

    CAS  Google Scholar 

  64. Young CR, Dietzsch C, Cerea M, Farrell T, Fegely KA, Rajabi-Siahboomi A, McGinity JW (2005) Physicochemical characterization and mechanisms of release of theophylline from melt-extruded dosage forms based on a methacrylic acid copolymer. Int J Pharm 301(1):112–120

    Article  CAS  Google Scholar 

  65. Li Y, Li H, Wei M, Lu J, Jin L (2009) pH-Responsive composite based on prednisone-block copolymer micelle intercalated inorganic layered matrix: structure and in vitro drug release. Chem Eng J 151(1):359–366

    Article  CAS  Google Scholar 

  66. Glaive A-S, Modjinou T, Versace D-L, Abbad-Andaloussi S, Dubot P, Langlois V, Renard E (2017) Design of antibacterial and sustainable antioxidant networks based on plant phenolic derivatives used as delivery system of carvacrol or tannic acid. ACS Sustain Chem Eng 5(3):2320–2329

    Article  CAS  Google Scholar 

  67. Gouda R, Baishya H, Qing Z (2017) Application of mathematical models in drug release kinetics of carbidopa and levodopa ER tablets. J Dev Drugs 6:171

    Google Scholar 

  68. Colombo P, Bettini R, Catellani PL, Santi P, Peppas NA (1999) Drug volume fraction profile in the gel phase and drug release kinetics in hydroxypropylmethyl cellulose matrices containing a soluble drug. Eur J Pharm Sci 9(1):33–40

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The research leading to these results has received funding from Department of Science and Technology (DST), New Delhi, India, under Extramural Research Grant: SB/S3/CE/068/2015.

Author information

Author notes

  1. Nidhi Gupta and Kalpana Pandey have contributed equally to this work.

Authors and Affiliations

  1. Department of Materials Science and Engineering, Indian Institute of Technology, Delhi, India

    Ashok Kr. Parthipan, Nidhi Gupta, Kalpana Pandey, Bhavna Sharma, Josemon Jacob & Sampa Saha

Authors
  1. Ashok Kr. Parthipan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nidhi Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kalpana Pandey
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bhavna Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Josemon Jacob
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sampa Saha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sampa Saha.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 3881 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Parthipan, A.K., Gupta, N., Pandey, K. et al. One-step fabrication of bicompartmental microparticles as a dual drug delivery system for Parkinson’s disease management. J Mater Sci 54, 730–744 (2019). https://doi.org/10.1007/s10853-018-2819-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10853-018-2819-x

Keywords

Search

Navigation